BIRC5 and cancer: Survivin has been investigated in various other cancers, such as pancreatic, adenocarcinoma, esophageal cancers, bladder and breast cancers; these studies have predominantly determined the mRNA expression levels in the cells, and found the expression levels of Survivin mRNA to be significantly elevated.